Gain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders, such as craniosynostosis and chondrodysplasia, which severely affect ...
To determine the biological significance of FGF receptor (FGFR) activation in human prostate cancer, we disrupted FGF signaling by transfection of dominant negative FGFR in a vector containing a ...
A new study explores the potential of fibroblast growth factor receptor (FGFR) antagonists in restoring defective mandibular bone repair in mouse models of osteochondrodysplasia, a group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results